# Bridging Continents: Asia Pacific's Leadership in Clinical Research

Page: https://stenobird.com/podcast/moving-medicine-forward-6832193/bridging-continents-asia-pacific-s-leadership-in-clinical-research
Text version: https://stenobird.com/podcast/moving-medicine-forward-6832193/bridging-continents-asia-pacific-s-leadership-in-clinical-research.md
Podcast: [Moving Medicine Forward](https://stenobird.com/podcast/moving-medicine-forward-6832193)
Published: 2026-01-14T17:41:21+00:00
Episode link: https://podcasters.spotify.com/pod/show/moving-medicine-forward/episodes/Bridging-Continents-Asia-Pacifics-Leadership-in-Clinical-Research-e3dlcq5
Audio file: https://anchor.fm/s/eb715a20/podcast/play/113996037/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-0-14%2Fe1d2b61d-cd7b-ac39-b532-4151efa4439a.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/moving-medicine-forward-6832193/episodes/bridging-continents-asia-pacific-s-leadership-in-clinical-research
Duration seconds: 1769

## Resource

In this episode, host Jeremy Schrand welcomes Tim Schroeder, Founder & CEO of CTI, Jaqueline Aguiar, Managing Director of APAC/LATAM, and Dr. Ludwig Baumann, Global Regulatory Strategist, for an in-depth conversation about the Asia Pacific region’s growing impact on clinical research. Together, they explore how population diversity, regulatory innovation, and advanced therapies are shaping the future of clinical trials. The discussion highlights real-world examples, regional strategies, and the evolving role of technology and local expertise in bringing new therapies to patients worldwide. 01:33 Welcome to the guests and setting the stage for the discussion. 01:50 Key drivers behind Asia Pacific’s growth: globalization of research, population scale, rare disease focus, and the need for global market access. 03:04 Panelists discuss the region’s diversity, infrastructure maturation, and regulatory harmonization efforts (ASEAN guidelines, mutual recognition). 05:10 Addressing past concerns about research qualityin Asia Pacific and how they’ve been resolved. 06:15 CTI’s strategic expansion into Asia Pacific:doubling of work, global footprint, and real-world examples from COVID-19 vaccine trials in Singapore and Vietnam. 08:17 Operational hurdles: regulatory fragmentation, cultural and language diversity, and government investment in science and digital health. 10:10 Managing regulatory variability: importance of local expertise, adapting to evolving guidelines, and leveraging relationships with regulators. 12:10 Harmonization and efficiency: Singapore’s reliance model, Australia’s streamlined processes, and their influence as regional role models. 14:26 Decentralized and virtual trials post-COVID: remote monitoring, reasons for choosing Australia (speed, tax credits) v…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/moving-medicine-forward-6832193/episodes/bridging-continents-asia-pacific-s-leadership-in-clinical-research/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/moving-medicine-forward-6832193/bridging-continents-asia-pacific-s-leadership-in-clinical-research.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.